跳至主要内容
临床试验/CTRI/2024/10/075389
CTRI/2024/10/075389尚未招募2 期

Clinical Efficacy of Safoof Marzanjosh (Origanum majorana) in Hyperlipidemia - A Randomized Controlled Trial

Firdhaus RUMANA K1 个研究点 分布在 1 个国家目标入组 40 人开始时间: 2024年10月24日最近更新:

试验速览

阶段
2 期
状态
尚未招募
发起方
入组人数
40
试验地点
1
主要终点
reduction in lipid levels

研究概览

简要总结

Unani system of medicine is one of the oldest systems of medicine which is practiced worldwide as holistic, preventive and curative medicine.In Unani Medicine, humours (Akhlat) play a vital role in maintenance of health; imbalance of their proportion either qualitative or quantitative can cause disease. Akhlat refers to the body fluids under a wider perspective in the Unani Medicine based upon theory of humors, which presupposes the presence of four humors in the body: dam (blood), balgham (phlegm), safra (yellow bile), and sawda (black bile), and human body is made of ten types of Aza_e_muffarada of which Shahm (Fat) is one of the important constituents.  Unani literature has classified Shaham  (Fat) under various categories like Sameen and Rivaaj1.  Unani system has mentioned a number of functions of Shaham which corelates with modern system of medicine such as it gives energy and creates heat, helps to store energy, gives shape and protects our vital organs.Lipids(fat) are water insoluble molecules that are transported in protein capsule, which determines its density, the lipoproteins density determines the fate of the particle and its influence on metabolism.  Plasma lipoprotein levels are major modifiable risk factors for cardiovascular disease. Increased levels of atherogenic lipoproteins (especially LDL) contribute to the development of atherosclerosis. LDL-C (Low density Lipoproteins)

The cost of management of hyperlipidemia throughout the world is high.In 2010, the estimated global cost of treatment of Hyperlipidemia was USD 863 billion, which is expected to increase to USD 1044 billion by the year 203010.  But in Unani System of Medicine there are plenty of potential herbal drugs which are safe and cheaper in comparison with modern drugs. Hence an attempt is made to explore the abundant resources of Unani Medicine in management of Hyperlipidemia.

研究设计

研究类型
Interventional
分配方式
Randomized
盲法
None

入排标准

年龄范围
30.00 Year(s) 至 60.00 Year(s)(—)
性别
All

入选标准

  • Subjects of Hyperlipidemia were identified with laboratory testing and having the values of plasma total cholesterol more than 200mg/dl, LDL-C less than 190 mg/dl, TG less than 499 mg/dl.
  • Known cases of Hyperlipidemia with less than five years of disease history Known cases of type II Diabetes Mellitus, Hypothyroidism, obesity BMI less than 30 Age 30 to 60yrs and all gender.

排除标准

  • Age less than 30 yrs and more than 60 yrs Pregnancy, Lactation Total Cholesterol more than 400 KNOWN HYPERTENSIVE CASES Systolic above 180 Diastolic above 110 mm Hg Malignancies, CAD, TB, AIDS, and other comorbidities such as Ischemic Heart Disease, CCF etc.

结局指标

主要结局

reduction in lipid levels

时间窗: Baseline,45th day

次要结局

  • improvement in quality of life(45 days)

研究者

发起方
Firdhaus RUMANA K
申办方类型
Other [self]
责任方
Principal Investigator
主要研究者

DR.FIRDHAUS RUMANA.K

Arignar Anna Government Hospital of Indian Medicine, chennai

研究点 (1)

Loading locations...

相似试验